Inhalable Antimicrobials for Treatment of Bacterial Biofilm-Associated Sinusitis in Cystic Fibrosis Patients: Challenges and Drug Delivery Approaches
Bacterial biofilm-associated chronic sinusitis in cystic fibrosis (CF) patients caused by Pseudomonas aeruginosa infections and the lack of available treatments for such infections constitute a critical aspect of CF disease management. Currently, inhalation therapies to combat P. aeruginosa infectio...
Main Authors: | Sylvia Natalie Kłodzińska, Petra Alexandra Priemel, Thomas Rades, Hanne Mørck Nielsen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/17/10/1688 |
Similar Items
-
Use of inhaled tobramycin in patients with cystic fibrosis
by: A G Chermensky, et al.
Published: (2010-08-01) -
Nebulizer Care and Inhalation Technique in Children with Cystic Fibrosis
by: Argyri Petrocheilou, et al.
Published: (2020-09-01) -
Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation
by: Imco Sibum, et al.
Published: (2019-05-01) -
The emergence of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis patients on inhaled antibiotics
by: Atqah AbdulWahab, et al.
Published: (2017-01-01) -
Treatment satisfaction in cystic fibrosis: early patient experience with tobramycin inhalation powder
by: Greenberg J, et al.
Published: (2016-10-01)